Loading stock data...
Last Updated: 10 Mar 2026, 03:29:58 PM (IST)

Dr. Agarwal's Health Care Limited

NSE: AGARWALEYE

NSE
446.30 -3.00 (-0.67%)

Prev Close

449.3

Open Price

447.95

Volume

60,356

Today Low / High

440.9 / 451.2

52 WK Low / High

327 / 568

Range

424 - 469

Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 446.3, with a change of -3 (-0.66771%). The expected target range on the NSE is between 424 - 469. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.

Dr. Agarwal's Health Care Limited Graph

Dr. Agarwal's Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Dr. Agarwal's Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 446.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 446.30 450.76 405.69 - 495.84
455.23 364.18 - 546.27
459.69 321.78 - 597.60
Bearish Scenario 446.30 441.84 397.65 - 486.02
437.37 349.90 - 524.85
432.91 303.04 - 562.78

Overview of Dr. Agarwal's Health Care Limited

ISIN

INE943P01029

Industry

Medical - Instruments & Supplies

Vol.Avg

157,643

Market Cap

141,993,121,500

Last Dividend

0

Official Website

Visit Website

IPO Date

2025-02-04

DCF Diff

356.00

DCF

92

Financial Ratios Every Investor Needs

Stock Rating Details for AGARWALEYE

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,711.00 Cr 719.71 Cr 991.29 Cr 0.5794 0.00 Cr 18.60 Cr 698.91 Cr 83.46 Cr 2.80 499.38 Cr 0.0488
2024-03-31 1,332.15 Cr 788.45 Cr 385.38 Cr 0.2893 0.00 Cr 29.08 Cr 515.45 Cr 101.69 Cr 2.70 450.07 Cr 0.0763
2023-03-31 1,016.48 Cr 559.17 Cr 296.14 Cr 0.2913 0.00 Cr 23.42 Cr 149.00 Cr 94.10 Cr 3.06 283.86 Cr 0.0926
2022-03-31 695.27 Cr 386.15 Cr 190.83 Cr 0.2745 0.00 Cr 17.93 Cr 88.58 Cr 37.69 Cr 1.23 196.12 Cr 0.0542
2021-03-31 471.18 Cr 183.89 Cr 287.29 Cr 0.6097 5.25 Cr 11.28 Cr 263.92 Cr -55.48 Cr -1.80 42.87 Cr -0.1177

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 258.13 Cr 3,671.57 Cr 1,744.75 Cr 1,866.5900 Cr 960.91 Cr 702.78 Cr 80.27 Cr 1,484.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 477.7600 Cr
2024-03-31 111.75 Cr 2,782.62 Cr 1,389.49 Cr 1,347.6370 Cr 967.88 Cr 856.13 Cr 51.90 Cr 1,145.18 Cr 0.00 Cr 0.00 Cr -440.91 Cr 414.6920 Cr
2023-03-31 126.98 Cr 1,825.17 Cr 1,166.10 Cr 629.5570 Cr 857.35 Cr 730.37 Cr 36.04 Cr 903.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 301.3150 Cr
2022-03-31 99.62 Cr 1,026.13 Cr 792.31 Cr 212.3770 Cr 618.56 Cr 518.94 Cr 32.92 Cr 547.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 206.0030 Cr
2021-03-31 55.21 Cr 786.99 Cr 588.29 Cr 184.2359 Cr 468.63 Cr 413.42 Cr 27.87 Cr 452.21 Cr 0.00 Cr 0.00 Cr 0.00 Cr 150.4396 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 331.4400 Cr -753.6800 Cr 414.0900 Cr 22.7900 Cr 146.2920 Cr 258.1300 Cr -320.9000 Cr 83.4600 Cr -141.0300 Cr -0.7900 Cr -26.4800 Cr
2024-03-31 345.9580 Cr -913.8610 Cr 552.6710 Cr 113.6430 Cr -15.2320 Cr 111.7490 Cr -232.3150 Cr 140.5680 Cr 29.5490 Cr -0.7730 Cr -15.2830 Cr
2023-03-31 233.1060 Cr -509.0850 Cr 303.3390 Cr 75.3050 Cr 27.3600 Cr 126.9810 Cr -157.8010 Cr 83.5910 Cr 95.1200 Cr -0.4280 Cr -2.4920 Cr
2022-03-31 164.3280 Cr -155.3510 Cr 35.4330 Cr 93.7400 Cr 44.4100 Cr 99.6210 Cr -70.5880 Cr 56.7630 Cr 92.5590 Cr -0.0070 Cr -4.6890 Cr
2021-03-31 99.1589 Cr -36.5693 Cr -37.1071 Cr -27.3945 Cr 55.2118 Cr 55.2118 Cr -126.5534 Cr -55.4783 Cr -16.2772 Cr 0.0000 Cr 5.5703 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 529.86 Cr 370.83 Cr 159.03 Cr 0.3001 75.35 Cr 33.74 Cr 1.07 154.64 Cr 0.0637
2025-09-30 498.69 Cr 345.43 Cr 153.26 Cr 0.3073 68.28 Cr 29.69 Cr 0.94 144.07 Cr 0.0595
2025-06-30 487.42 Cr 275.48 Cr 211.94 Cr 0.4348 64.91 Cr 30.05 Cr 0.95 141.25 Cr 0.0617
2025-03-31 460.22 Cr 191.38 Cr 268.84 Cr 0.5842 194.10 Cr 32.57 Cr 1.04 143.92 Cr 0.0708
2024-12-31 430.72 Cr 177.85 Cr 252.87 Cr 0.5871 179.36 Cr 22.34 Cr 0.73 93.76 Cr 0.0519

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 189.20 Cr 207.51 Cr 396.71 Cr 138.16 Cr 78.38 Cr 655.92 Cr 1,709.15 Cr 3,786.12 Cr 1,767.44 Cr
2025-06-30 0.00 Cr 0.00 Cr 512.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,926.82 Cr
2025-03-31 258.13 Cr 263.73 Cr 521.86 Cr 123.56 Cr 80.27 Cr 794.07 Cr 1,484.34 Cr 3,671.57 Cr 1,744.75 Cr
2024-12-31 490.93 Cr 0.00 Cr 490.93 Cr 0.00 Cr 0.00 Cr 490.93 Cr 0.00 Cr 0.00 Cr -1,558.13 Cr
2024-09-30 166.76 Cr 324.17 Cr 490.93 Cr 120.14 Cr 68.71 Cr 718.92 Cr 1,311.60 Cr 3,393.41 Cr 1,835.28 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 30.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 32.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 22.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 14.28 Cr 100.99 Cr -222.00 Cr 148.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr -63.45 Cr 37.54 Cr
2024-06-30 14.28 Cr 100.99 Cr -222.00 Cr 148.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr -63.45 Cr 37.54 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Instruments & Supplies

Company Name Symbol Price Market Cap Volume
Dr. Agarwal's Health Care Limited AGARWALEYE ₹446.30 ₹141,391,187,250.00 ₹60,356.00
Poly Medicure Limited POLYMED ₹1,283.60 ₹130,105,041,364.00 ₹350,693.00
Shaily Engineering Plastics Limited SHAILY ₹1,886.00 ₹86,671,305,398.00 ₹174,111.00

Key Executives

Chief Executive Officer & Whole-Time Director
Adil Agarwal

Gender: Not Specified

Year Born: 1983

Chief Operating Officer & Wholetime Director
Anosh Agarwal Ophthal

Gender: Not Specified

Year Born: 1984

Chief Business Officer
Ashar Agarwal

Gender: Not Specified

Year Born: 1985

Chief Clinical Officer
Ashvin Agarwal

Gender: Not Specified

Year Born: 1983

Chief Strategy Officer
Vandana Jain

Gender: Not Specified

Year Born:

Chief Operating Officer- Hospital Operations
Rahul Agarwal

Gender: male

Year Born:

Vice President of Corporate Affairs, Company Secretary & Compliance Officer
Thanikainathan Arumugam

Gender: male

Year Born:

Chief Financial Officer
Yashwanth Venkat

Gender: male

Year Born: 1985

Head of Investor Relations
Aashna Dharia

Gender: female

Year Born:

FAQs about Dr. Agarwal's Health Care Limited

Who is the CEO of the company?

The CEO is Adil Agarwal.

What is the current market price of the stock?

The current price is ₹448.20.

What is the 52-week price range?

The range is ₹327-568.

What is the market capitalization of the company?

The market capitalization is ₹14,199.31 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 112.12.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Dr. Agarwal's Health Care Limited (ISIN: INE943P01029) is a leading Medical - Instruments & Supplies in India. With a market capitalization of ₹14,199.31 crores and an average daily volume of 157,643 shares, it operates in the Medical - Instruments & Supplies. The company last declared a dividend of ₹0.